Download the paper summary of the recent Cell publication, "Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19," to see how IsoPlexis' functional immune landscaping revealed key prognostic biomarkers of COVID-19 severity.
IsoPlexis' technology identified unique prognostic immune biomarkers of COVID-19, which help researchers understand and combat the underlying mechanisms driving disease progression.
